EU-PEARL to contribute to the debate on patient centricity in Eye for Pharma

As patient centric approach has become a top priority in drug development and clinical research, debate intensifies on how best industry and researchers can foster this new model. With a view to continue facilitating dialogue between industry and patient stakeholders, Eye for Pharma 2020 will take place virtually next September 15th and 16th. Valentina Strammiello, senior manager at the European Patient Forum (EPF) and member of EU-PEARL will present the project and explain how it plans to build an innovative framework of platform trials which has the patient at the centre.